首页> 美国卫生研究院文献>PLoS Clinical Trials >Differential Effects of Rapamycin and Dexamethasone in Mouse Models of Established Allergic Asthma
【2h】

Differential Effects of Rapamycin and Dexamethasone in Mouse Models of Established Allergic Asthma

机译:雷帕霉素和地塞米松在已建立的过敏性哮喘小鼠模型中的差异作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The mammalian target of rapamycin (mTOR) plays an important role in cell growth/differentiation, integrating environmental cues, and regulating immune responses. Our lab previously demonstrated that inhibition of mTOR with rapamycin prevented house dust mite (HDM)-induced allergic asthma in mice. Here, we utilized two treatment protocols to investigate whether rapamycin, compared to the steroid, dexamethasone, could inhibit allergic responses during the later stages of the disease process, namely allergen re-exposure and/or during progression of chronic allergic disease. In protocol 1, BALB/c mice were sensitized to HDM (three i.p. injections) and administered two intranasal HDM exposures. After 6 weeks of rest/recovery, mice were re-exposed to HDM while being treated with rapamycin or dexamethasone. In protocol 2, mice were exposed to HDM for 3 or 6 weeks and treated with rapamycin or dexamethasone during weeks 4–6. Characteristic features of allergic asthma, including IgE, goblet cells, airway hyperreactivity (AHR), inflammatory cells, cytokines/chemokines, and T cell responses were assessed. In protocol 1, both rapamycin and dexamethasone suppressed goblet cells and total CD4+ T cells including activated, effector, and regulatory T cells in the lung tissue, with no effect on AHR or total inflammatory cell numbers in the bronchoalveolar lavage fluid. Rapamycin also suppressed IgE, although IL-4 and eotaxin 1 levels were augmented. In protocol 2, both drugs suppressed total CD4+ T cells, including activated, effector, and regulatory T cells and IgE levels. IL-4, eotaxin, and inflammatory cell numbers were increased after rapamycin and no effect on AHR was observed. Dexamethasone suppressed inflammatory cell numbers, especially eosinophils, but had limited effects on AHR. We conclude that while mTOR signaling is critical during the early phases of allergic asthma, its role is much more limited once disease is established.
机译:雷帕霉素(mTOR)的哺乳动物靶标在细胞生长/分化,整合环境提示和调节免疫反应中起重要作用。我们的实验室先前证明,雷帕霉素对mTOR的抑制作用可预防屋尘螨(HDM)诱发的小鼠过敏性哮喘。在这里,我们利用两种治疗方案来研究雷帕霉素(与类固醇地塞米松相比)在疾病过程的后期(即过敏原再暴露和/或慢性过敏性疾病进展期间)是否可以抑制过敏反应。在方案1中,将BALB / c小鼠对HDM进行敏化(3次腹膜内注射),并进行两次鼻内HDM暴露。休息/恢复6周后,在用雷帕霉素或地塞米松治疗的同时,将小鼠再次暴露于HDM。在方案2中,将小鼠暴露于HDM 3或6周,并在4-6周内用雷帕霉素或地塞米松治疗。评估了过敏性哮喘的特征,包括IgE,杯状细胞,气道高反应性(AHR),炎症细胞,细胞因子/趋化因子和T细胞反应。在方案1中,雷帕霉素和地塞米松均能抑制杯状细胞和总的CD4 + T细胞,包括肺组织中的活化,效应和调节性T细胞,而对AHR或总炎症细胞数没有影响支气管肺泡灌洗液。雷帕霉素还抑制了IgE,尽管IL-4和嗜酸性粒细胞趋化因子1的水平增加了。在方案2中,两种药物均抑制总CD4 + T细胞,包括激活的,效应子和调节性T细胞和IgE水平。雷帕霉素治疗后IL-4,嗜酸性粒细胞趋化因子和炎性细胞数量增加,但未观察到对AHR的影响。地塞米松抑制炎性细胞数量,尤其是嗜酸性粒细胞,但对AHR的作用有限。我们得出的结论是,尽管mTOR信号传导在变应性哮喘的早期阶段至关重要,但一旦疾病确立,其作用将更加有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号